Health Trials

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study of Cizutamig in Thyroid Eye Disease

The purpose of this study is to evaluate the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of cizutamig in patients with thyroid eye disease (TED).

Participants needed: 38
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Candid TherapeuticsUpdated: May 19, 2026Locations: 1
Eligibility criteria

18-75 years old at the time of signing the Informed Consent Form [+1]

Inadequate clinical laboratory parameters at Screening [+11]

Read more
Status: Not yet recruiting

A Phase 1 Study of Cizutamig in IgE Mediated Diseases

The purpose of this study is to evaluate the pharmacodynamics, safety, tolerability, pharmacokinetics, and immunogenicity of cizutamig in IgE Mediated Diseases.

Participants needed: 20
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Candid TherapeuticsUpdated: Apr 16, 2026Locations: 1
Eligibility criteria

History of documented (skin prick test, in vitro testing, or food challenge), on... [+6]

Elevated IgE levels for reasons other than the IgE mediated diseases [+19]

Read more
Status: Recruiting

Clinical Study of Cizutamig in Systemic Lupus Erythematosus

The purpose of this study is to assess the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of Cizutamig in patients with Systemic Lupus Erythematosus

Participants needed: 47
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Candid TherapeuticsUpdated: Nov 17, 2025Locations: 1
Eligibility criteria

18 to 75 years old at the time of signing the informed consent form [+6]

Inadequate clinical laboratory parameters at Screening [+19]

Read more
Status: Recruiting

Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

The purpose of this study is to assess the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of Cizutamig in patients with Generalized Myasthenia Gravis.

Participants needed: 44
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Candid TherapeuticsUpdated: Nov 17, 2025Locations: 1
Eligibility criteria

At least 18 years old at the time of signing the Informed Consent Form (ICF); [+3]

Any history of CAR-T or TCE therapy targeting any antigen or BCMA-targeted thera... [+10]

Read more